剧场上的设备代表:模糊的界限或监管漏洞?
Bernadette Richards1, Susannah Sage Jacobson2, Brette Blakely3
1Academy for Medical Education, Medical School, The University of Queensland, 288 Herston Rd, Herston, QLD, 4006, Australia. bernadette.richards@uq.edu.au.
Monash bioethics review
|June 24, 2025
概括
医疗器械代表 (MDR) 越来越多地向外科医生提供建议,模糊了销售和支持线路. 虽然存在法规,但它们的本地实施和适应滞后,可能会影响患者的安全和信任.
科学领域:
- 医疗保健技术 医疗保健技术 医疗保健技术
- 医疗器械监管法规 医疗器械监管法规
- 手术支持手术支持
背景情况:
- 技术进步正在重塑医疗保健和医生与患者之间的关系.
- 复杂的医疗器械需要技术专业知识超出传统的医疗培训.
- 医疗器械代表 (MDR) 从销售角色演变为顾问和培训师,造成了潜在的利益冲突.
研究的目的:
- 检查MDRs,外科医生和患者之间的不断变化的关系.
- 评估利益相关者对MDR在医疗保健环境中的角色的看法.
- 评估澳大利亚医院对MDRs的现有监管框架.
主要方法:
- 基于对利益相关者的采访进行的定性研究.
- 在医疗器械销售和患者护理的交叉点对感知和经验的分析.
- 审查有关医院安全,隐私,职业行为和利益冲突的监管措施.
主要成果:
- 随着MDRs的不断变化的作用并非在监管真空中发生;存在足够的框架.
- 现有法规需要有效地转化为当地医院政策和最佳实践.
- 在适应最佳实践方面存在滞后,导致缺乏透明度和对新环境的认可.
结论:
- 有足够的监管框架来保护公众对MDRs.
- 地方政策实施和行为适应对于有效的监管至关重要.
- 在最佳实践和透明度方面的滞后可能会威胁到患者的安全和对医疗保健系统的信任.
更多相关视频
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
240
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
240
Global Regulatory Systems
71
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
71
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Pharmacovigilance
981
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
981
Masking and Demasking Agents
2.6K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
2.6K
Regulation of Expression at Multiple Steps
994
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
994


